Latest stories on DERM
Journey Medical price target lowered to $13 from $15 at B. Riley
The Fly34 · bearishanalyst
Journey Medical (DERM) Q3 2026 Earnings Call Transcript
The Motley Fool64 · neutralearnings
Journey Medical (DERM) Reports 8% Revenue Growth in Q3 2026 Amid Mixed Valuation Signals
GuruFocus58 · neutralearnings
Journey Medical anticipates Emrosi addition to a national plan with over 25M lives beginning 2027
Seeking Alpha64 · neutralproduct/pr
Journey Medical Corporation (DERM) Q3 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Journey Medical GAAP EPS of -$0.05 misses by $0.03, revenue of $19M misses by $1.32M
Business Insider34 · bearishearnings
Journey Medical reports Q3 adjusted EPS 12c vs. 5c last year
The Fly64 · neutralearnings
Journey Medical Corp (DERM) files 8-K: Items 2.02, 9.01
SEC 8-K50 · neutralgeneral
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
StockTitan55 · neutralearnings
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire56 · neutralearnings
Journey Medical Q3 Earnings Preview
Seeking Alpha50 · neutralearnings
Earnings To Watch: Journey Medical Corp (DERM) Q3 2026 -- GF Value Sees 76% Upside
GuruFocus64 · neutralearnings
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
GlobeNewswire50 · neutralgeneral
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
Business Insider50 · neutralgeneral
Journey Medical: A Small Pharma With A Large Growth Opportunity
Seeking Alpha67 · bullishproduct/pr
Journey Medical Corporation to Participate in September 2026 Investor Conferences
GlobeNewswire56 · neutralgeneral
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Business Insider56 · neutralgeneral
Journey Medical’s Earnings Call Signals Breakout Momentum
TipRanks73 · bullishearnings
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
Yahoo Top63 · neutralearnings
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction
Seeking Alpha73 · bullishearnings
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
DERM Revenue Jumps 23% as Emrosi® Momentum Drives Profitability Path—Margins, Cash, and Prescriptions All Up
August 13, 2026
MarketChameleon67 · bullishearnings
Why is Journey Medical stock rallying today?
Investing.com Markets50 · neutralgeneral
Journey Medical Corporation Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings